Prudential Financial
NRIX icon

Prudential Financial’s Nurix Therapeutics NRIX Stock Holding History

Prudential Financial’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.52M Buy
145,170
+100,970
+228% +$1.72M ﹤0.01% 1153
2026
Q1 		$685K Buy
+44,200
New +$733K ﹤0.01% 1743
2022
Q1 		– Sell
-41,495
Closed -$1.23M – 2665
2021
Q4 		$1.23M Buy
41,495
+12,775
+44% +$387K ﹤0.01% 1787
2021
Q3 		$861K Buy
28,720
+20
+0.1% +$617 ﹤0.01% 1893
2021
Q2 		$762K Buy
28,700
+750
+3% +$22K ﹤0.01% 1963
2021
Q1 		$869K Buy
+27,950
New +$1.06M ﹤0.01% 1901

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Prudential Financial's NRIX Position: Q2 2026 in Review

Prudential Financial increased its Nurix Therapeutics (NRIX) stake by 228% in Q2 2026, buying an estimated $1.72M and bringing the position to 145,170 shares worth $3.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1153.

Prudential Financial first reported a position in NRIX in Q1 2021 and has held it in 6 quarters since. 212 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Prudential Financial held 145,170 shares of Nurix Therapeutics worth $3.52M as of Q2 2026.
  • Prudential Financial bought 100,970 Nurix Therapeutics shares in Q2 2026, an estimated $1.72M.
  • Nurix Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1153 holding.
  • Prudential Financial first reported a position in Nurix Therapeutics in Q1 2021 and has held it in 6 quarters since.
  • 212 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.